oxsoralen-ultra- methoxsalen capsule, liquid filled
bausch health us, llc - methoxsalen (unii: u4vj29l7bq) (methoxsalen - unii:u4vj29l7bq) - methoxsalen 10 mg - photochemotherapy (methoxsalen with long-wave uva radiation) is indicated for the symptomatic control of severe, recalcitrant, disabling psoriasis not adequately responsive to other forms of therapy and when the diagnosis has been supported by biopsy. methoxsalen is intended to be administered only in conjunction with a schedule of controlled doses of long-wave ultraviolet radiation. a. patients exhibiting idiosyncratic reactions to psoralen compounds. b. patients possessing a specific history of light-sensitive disease states should not initiate methoxsalen therapy except under special circumstances. diseases associated with photosensitivity include lupus erythematosus, porphyria cutanea tarda, erythropoietic protoporphyria, variegate porphyria, xeroderma pigmentosum, and albinism. c. patients with melanoma or with a history of melanoma. d. patients with invasive squamous cell carcinomas. e. patients with aphakia because of the significantly increased risk of retinal damage due to the absence of lenses.
oxsoralen 20 mcgml
a.l. medi-market ltd. - methoxsalen - solution for blood fraction modification - methoxsalen 20 mcg / 1 ml - methoxsalen - oxsoralen is indicated in adults for extracorporeal use in the palliative treatment of advanced stage cutaneous t-cell lymphoma in patients who have not been responsive to other forms of treatment
arcade herbicide
syngenta australia pty ltd - prosulfocarb - emulsifiable concentrate - prosulfocarb carbamate-thiocarbamate active 800.0 g/l - herbicide
skarcade gel-pad kit-
plum valley pharma llc - indications gel sheeting is intended for use in the management, control, and prevention of old and new hypertrophic or keloid scars resulting from burns or surgical or traumatic injury of the skin. contraindications do not use on open wounds or when any dermatological conditions disrupt the skin (such as a rash). instructions for use silicone gel sheeting - wash both scar and hands per cleaning instructions. - open the non-sterile pouch containing the silicone gel sheet. - clear gel sheeting is covered on both sides by a plastic film. fabric gel sheeting is covered on the tacky side by a plastic film. remove plastic film prior to use. - the gel sheet may be cut into smaller pieces using scissors or a scalpel. once you have determined the appropriate size of sheeting to use, apply tacky side to the scar. the gel sheeting should fully cover the scar and extend ¼ inch all the way around the scar border. - the exposed surface of the gel sheeting may be covered wi
yosprala- aspirin and omeprazole tablet, film coated
aralez pharmaceuticals us inc. - aspirin (unii: r16co5y76e) (aspirin - unii:r16co5y76e), omeprazole (unii: kg60484qx9) (omeprazole - unii:kg60484qx9) - aspirin 81 mg - yosprala, a combination of aspirin and omeprazole, is indicated for patients who require aspirin for secondary prevention of cardiovascular and cerebrovascular events and who are at risk of developing aspirin associated gastric ulcers. the aspirin component of yosprala is indicated for: - reducing the combined risk of death and nonfatal stroke in patients who have had ischemic stroke or transient ischemia of the brain due to fibrin platelet emboli, - reducing the combined risk of death and nonfatal mi in patients with a previous mi or unstable angina pectoris, - reducing the combined risk of mi and sudden death in patients with chronic stable angina pectoris, - use in patients who have undergone revascularization procedures (coronary artery bypass graft [cabg] or percutaneous transluminal coronary angioplasty [ptca]) when there is a pre-existing condition for which aspirin is already indicated. the omeprazole component of yosprala is indicated for decreasing the risk of developing aspirin-associated gastric u
oxsoralen-ultra cap 10mg capsule
valeant canada lp / valeant canada s.e.c. - methoxsalen - capsule - 10mg - methoxsalen 10mg - pigmenting agents
oxsoralen lot 10mg/ml lotion
valeant canada lp / valeant canada s.e.c. - methoxsalen - lotion - 10mg - methoxsalen 10mg - pigmenting agents
oxsoralen cap 10mg capsule
valeant canada lp / valeant canada s.e.c. - methoxsalen - capsule - 10mg - methoxsalen 10mg - pigmenting agents
zontivity- vorapaxar tablet, film coated
aralez pharmaceuticals us inc. - vorapaxar sulfate (unii: in66038e6c) (vorapaxar - unii:zce93644n2) - vorapaxar 2.08 mg - zontivity ® is indicated for the reduction of thrombotic cardiovascular events in patients with a history of myocardial infarction (mi) or with peripheral arterial disease (pad). zontivity has been shown to reduce the rate of a combined endpoint of cardiovascular death, mi, stroke, and urgent coronary revascularization (ucr). zontivity is contraindicated in patients with a history of stroke, tia, or ich because of an increased risk of ich in this population [see adverse reactions (6)] . discontinue zontivity in patients who experience a stroke, tia, or ich [see adverse reactions (6.1) and clinical studies (14)] . zontivity is contraindicated in patients with active pathological bleeding such as ich or peptic ulcer [see warnings and precautions (5.1) and adverse reactions (6.1)] . risk summary based on the potenti
aralen tablet
sanofi-synthelabo canada inc - chloroquine phosphate - tablet - 250mg - chloroquine phosphate 250mg - antimalarials